Welcome to LookChem.com Sign In|Join Free
  • or
2,4,6-Tris(2-chloroethyl)-1,3,5-trioxane, also known as TCT or Trimustine, is a nitrogen mustard alkylating agent with potent anticancer properties. It is a chemical compound that targets and damages the DNA of cancer cells, thereby inhibiting their division and leading to cell death. TCT is typically administered intravenously and is often used in combination with other chemotherapy drugs to enhance treatment efficacy.

15678-07-6

Post Buying Request

15678-07-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15678-07-6 Usage

Uses

Used in Oncology:
2,4,6-Tris(2-chloroethyl)-1,3,5-trioxane is used as a chemotherapeutic agent for the treatment of various types of cancer, including lymphomas, melanomas, and lung cancers. Its alkylating action causes DNA damage in cancer cells, disrupting their ability to divide and proliferate, ultimately leading to cell death.
Used in Combination Therapy:
2,4,6-Tris(2-chloroethyl)-1,3,5-trioxane is used as a component of combination chemotherapy regimens to enhance the overall effectiveness of cancer treatment. When used in conjunction with other chemotherapy drugs, TCT can improve the therapeutic outcomes by targeting different aspects of cancer cell biology and overcoming drug resistance.
Used in Cancer Research:
2,4,6-Tris(2-chloroethyl)-1,3,5-trioxane is also used as a research tool in the study of cancer biology and the development of novel anticancer therapies. Its mechanism of action and side effects provide valuable insights into the challenges and opportunities in cancer treatment, guiding the design of more effective and targeted therapies.
Despite its potential side effects, such as nausea, vomiting, and bone marrow suppression, 2,4,6-Tris(2-chloroethyl)-1,3,5-trioxane is generally well-tolerated by patients and remains an important agent in the fight against cancer. Its versatility in combination therapies and its role in advancing cancer research underscore its significance in the field of oncology.

Check Digit Verification of cas no

The CAS Registry Mumber 15678-07-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,6,7 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15678-07:
(7*1)+(6*5)+(5*6)+(4*7)+(3*8)+(2*0)+(1*7)=126
126 % 10 = 6
So 15678-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H15Cl3O3/c10-4-1-7-13-8(2-5-11)15-9(14-7)3-6-12/h7-9H,1-6H2

15678-07-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4,6-tris(2-chloroethyl)-1,3,5-trioxane

1.2 Other means of identification

Product number -
Other names 2.4.6-Tris-<2-chlor-aethyl>-1.3.5-trioxan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15678-07-6 SDS

15678-07-6Upstream product

15678-07-6Downstream Products

15678-07-6Relevant academic research and scientific papers

Synthesis of 2-Hydroxybut-3-enylglucosinolate (Progoitrin)

MacLeod, Alexander J.,Rossiter, John T.

, p. 717 - 721 (1983)

A synthesis of 2-hydroxybut-3-enylglucosinolate (progoitrin) is described.Its properties and authentication of its biological activity are discussed.This is the first time that this particular glucosinolate has been isolated in pure form by synthesis.

H-type zeolite-catalyzed 1,4-addition of benzene derivatives to labile acrolein

Hayashi, Daijiro,Narisawa, Tomoyuki,Masui, Yoichi,Onaka, Makoto

supporting information, p. 460 - 471 (2016/04/26)

The 1,4-addition of benzene derivatives to acrolein is a straightforward way to synthesize 3-arylpropanals. A survey of acid catalysts for the 1,4-addition of methoxy-substituted benzenes to acrolein revealed that H-Beta and H-Y were the most suitable catalysts. We hypothesized three side-reactions: (1) the double 1,4-addition of acrolein to the starting benzene derivatives, (2) the Friedel-Crafts-type alkylation to the desired product, and (3) the self-polymerization of acrolein. The type (3) side-reaction was inhibited by two different methods which kept the concentration of acrolein low in the reaction mixture or in the zeolite pores. First, acrolein monomers were in situ generated through the gradual monomerization of an acrolein cyclic trimer. Second, using a reaction solvent lowered the acrolein concentration in the zeolite pores due to the competitive adsorption. We discovered that the content of monomeric acrolein in a solvent was closely related to the polarity of the solvent. Actually, both methods improved the yields for the 1,4-additions of 1,3-dimethoxybenzene to acrolein. Other electron-rich benzene derivatives, such as phenol and N, N-dimethylaniline, were also applicable to the 1,4-addition reactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15678-07-6